Fresenius | FRE - Ebit

Stock Price
48.99
Daily Change
1.03 2.15%
Monthly
2.73%
Yearly
32.69%
Q1 Forecast
45.82

Fresenius reported EUR574M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Akzo Nobel EUR 297M 6M Sep/2025
Alcon AG USD 334M 84M Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
BASF EUR 493M 334M Sep/2025
Bayer EUR -399M 363M Sep/2025
Beiersdorf EUR 816M 370M Jun/2025
DaVita Healthcare Partners USD 459.36M 55.63M Sep/2025
Demant DKK 2.07B 201M Dec/2025
E.ON EUR 709M 548M Sep/2025
Essilor EUR 2B 20M Jun/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
Getinge SEK 2.02B 1.2B Dec/2024
Givaudan CHF 756M 221M Jun/2024
GlaxoSmithKline GBP 2.79B 716M Sep/2025
GN Store Nord DKK 340M 121M Sep/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Lonza CHF 673M 54M Jun/2025
Merck EUR 1.21B 180M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Philips EUR 329M 159M Sep/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
RWE EUR 1.43B 791M Sep/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Smith & Nephew USD 440M 50M Dec/2025